Kafili Golara, Niknejad Hassan, Tamjid Elnaz, Simchi Abdolreza
Center for Nanoscience and Nanotechnology, Institute for Convergence Science and Technology, Sharif University of Technology, Tehran, Iran.
Department of Pharmacology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Front Bioeng Biotechnol. 2024 Feb 26;12:1358977. doi: 10.3389/fbioe.2024.1358977. eCollection 2024.
In recent years, the amnion (AM) has emerged as a versatile tool for stimulating tissue regeneration and has been of immense interest for clinical applications. AM is an abundant and cost-effective tissue source that does not face strict ethical issues for biomedical applications. The outstanding biological attributes of AM, including side-dependent angiogenesis, low immunogenicity, anti-inflammatory, anti-fibrotic, and antibacterial properties facilitate its usage for tissue engineering and regenerative medicine. However, the clinical usage of thin AM sheets is accompanied by some limitations, such as handling without folding or tearing and the necessity for sutures to keep the material over the wound, which requires additional considerations. Therefore, processing the decellularized AM (dAM) tissue into a temperature-sensitive hydrogel has expanded its processability and applicability as an injectable hydrogel for minimally invasive therapies and a source of bioink for the fabrication of biomimetic tissue constructs by recapitulating desired biochemical cues or pre-defined architectural design. This article reviews the multi-functionality of dAM hydrogels for various biomedical applications, including skin repair, heart treatment, cartilage regeneration, endometrium regeneration, vascular graft, dental pulp regeneration, and cell culture/carrier platform. Not only recent and cutting-edge research is reviewed but also available commercial products are introduced and their main features and shortcomings are elaborated. Besides the great potential of AM-derived hydrogels for regenerative therapy, intensive interdisciplinary studies are still required to modify their mechanical and biological properties in order to broaden their therapeutic benefits and biomedical applications. Employing additive manufacturing techniques (e.g., bioprinting), nanotechnology approaches (e.g., inclusion of various bioactive nanoparticles), and biochemical alterations (e.g., modification of dAM matrix with photo-sensitive molecules) are of particular interest. This review article aims to discuss the current function of dAM hydrogels for the repair of target tissues and identifies innovative methods for broadening their potential applications for nanomedicine and healthcare.
近年来,羊膜(AM)已成为促进组织再生的多功能工具,并在临床应用中引起了极大的兴趣。羊膜是一种丰富且具有成本效益的组织来源,在生物医学应用中不存在严格的伦理问题。羊膜出色的生物学特性,包括促血管生成、低免疫原性、抗炎、抗纤维化和抗菌特性,使其在组织工程和再生医学中得到应用。然而,薄羊膜片的临床应用存在一些局限性,例如在处理时不能折叠或撕裂,并且需要缝合以将材料固定在伤口上,这需要额外考虑。因此,将脱细胞羊膜(dAM)组织加工成温度敏感水凝胶,扩大了其作为可注射水凝胶用于微创治疗的可加工性和适用性,以及作为生物墨水用于通过重现所需生化线索或预定义结构设计来制造仿生组织构建体的来源。本文综述了dAM水凝胶在各种生物医学应用中的多功能性,包括皮肤修复、心脏治疗、软骨再生、子宫内膜再生、血管移植、牙髓再生以及细胞培养/载体平台。不仅回顾了近期的前沿研究,还介绍了现有的商业产品,并阐述了它们的主要特点和缺点。除了AM衍生水凝胶在再生治疗方面的巨大潜力外,仍需要深入的跨学科研究来改变其机械和生物学特性,以扩大其治疗益处和生物医学应用。采用增材制造技术(如生物打印)、纳米技术方法(如包含各种生物活性纳米颗粒)和生化改变(如用光敏感分子修饰dAM基质)特别受关注。这篇综述文章旨在讨论dAM水凝胶目前在修复靶组织方面的功能,并确定拓宽其在纳米医学和医疗保健领域潜在应用的创新方法。